These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 18970153)

  • 1. Simple and highly predictive QSAR method: application to a series of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxybenzamides.
    Freitas MP; Martins JA
    Talanta; 2005 Jul; 67(1):182-6. PubMed ID: 18970153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multiway 3D QSAR analysis of a series of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxybenzamides.
    Nilsson J; Homan EJ; Smilde AK; Grol CJ; Wikström H
    J Comput Aided Mol Des; 1998 Jan; 12(1):81-93. PubMed ID: 9570091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of multivariate image analysis applied to quantitative structure-activity relationship (QSAR) analysis by using wavelet-principal component analysis ranking variable selection and least-squares support vector machine regression: QSAR study of checkpoint kinase WEE1 inhibitors.
    Cormanich RA; Goodarzi M; Freitas MP
    Chem Biol Drug Des; 2009 Feb; 73(2):244-52. PubMed ID: 19207427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative structure-activity relationship for some dopamine D2 antagonists of benzamide type.
    Norinder U; Högberg T
    Acta Pharm Nord; 1992; 4(2):73-8. PubMed ID: 1388772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 3D QSAR study on a set of dopamine D4 receptor antagonists.
    Boström J; Böhm M; Gundertofte K; Klebe G
    J Chem Inf Comput Sci; 2003; 43(3):1020-7. PubMed ID: 12767161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR modeling on dopamine D2 receptor binding affinity of 6-methoxy benzamides.
    Samanta S; Debnath B; Gayen S; Ghosh B; Basu A; Srikanth K; Jha T
    Farmaco; 2005 Oct; 60(10):818-25. PubMed ID: 16055122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
    Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
    Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative structure-activity relationship studies of threo-methylphenidate analogs.
    Misra M; Shi Q; Ye X; Gruszecka-Kowalik E; Bu W; Liu Z; Schweri MM; Deutsch HM; Venanzi CA
    Bioorg Med Chem; 2010 Oct; 18(20):7221-38. PubMed ID: 20846865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors.
    Kuo CL; Assefa H; Kamath S; Brzozowski Z; Slawinski J; Saczewski F; Buolamwini JK; Neamati N
    J Med Chem; 2004 Jan; 47(2):385-99. PubMed ID: 14711310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
    Wang XS; Tang H; Golbraikh A; Tropsha A
    J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-chiral quadratic indices of the 'molecular pseudograph's atom adjacency matrix' and their application to central chirality codification: classification of ACE inhibitors and prediction of sigma-receptor antagonist activities.
    Ponce YM; Diaz HG; Zaldivar VR; Torrens F; Castro EA
    Bioorg Med Chem; 2004 Oct; 12(20):5331-42. PubMed ID: 15388160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tandem 3D-QSARs approach as a valuable tool to predict binding affinity data: design of new Gly/NMDA receptor antagonists as a key study.
    Bacilieri M; Varano F; Deflorian F; Marini M; Catarzi D; Colotta V; Filacchioni G; Galli A; Costagli C; Kaseda C; Moro S
    J Chem Inf Model; 2007; 47(5):1913-22. PubMed ID: 17722877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding site.
    Kroemer RT; Koutsilieri E; Hecht P; Liedl KR; Riederer P; Kornhuber J
    J Med Chem; 1998 Jan; 41(3):393-400. PubMed ID: 9464369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods.
    Hoffman B; Cho SJ; Zheng W; Wyrick S; Nichols DE; Mailman RB; Tropsha A
    J Med Chem; 1999 Aug; 42(17):3217-26. PubMed ID: 10464009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of MOLMAP approach for QSAR modeling of various biological activities using substituent electronic descriptors.
    Hemmateenejad B; Mehdipour AR; Miri R; Shamsipur M
    J Comput Chem; 2009 Oct; 30(13):2001-9. PubMed ID: 19130500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity prediction of some nontested anticancer compounds using GA-based PLS regression models.
    Nandi S; Bagchi MC
    Chem Biol Drug Des; 2011 Oct; 78(4):587-95. PubMed ID: 21752199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of aryl-substituted N-(arylethyl)-N-methyl-2-(1-pyrrolidinyl)ethylamines and corresponding arylacetamides for sigma receptor affinity.
    Zhang Y; Williams W; Bowen WD; Rice KC
    J Med Chem; 1996 Aug; 39(18):3564-8. PubMed ID: 8784455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
    Roy K; Leonard JT
    J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.